Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Dumping Cambrex Corporation (CBM)

Page 1 of 2

Cambrex Corporation (NYSE:CBM) investors should pay attention to a decrease in hedge fund interest of late.

In the 21st century investor’s toolkit, there are tons of gauges shareholders can use to track the equity markets. A couple of the most innovative are hedge fund and insider trading sentiment. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite investment managers can outperform the S&P 500 by a superb margin (see just how much).

Chuck Royce

Equally as key, positive insider trading sentiment is a second way to parse down the investments you’re interested in. Obviously, there are lots of motivations for an upper level exec to downsize shares of his or her company, but only one, very obvious reason why they would initiate a purchase. Various academic studies have demonstrated the valuable potential of this strategy if you know where to look (learn more here).

With these “truths” under our belt, it’s important to take a peek at the recent action encompassing Cambrex Corporation (NYSE:CBM).

What does the smart money think about Cambrex Corporation (NYSE:CBM)?

At Q1’s end, a total of 11 of the hedge funds we track held long positions in this stock, a change of -21% from the first quarter. With hedge funds’ sentiment swirling, there exists a select group of noteworthy hedge fund managers who were boosting their stakes considerably.

According to our comprehensive database, Chuck Royce’s Royce & Associates had the most valuable position in Cambrex Corporation (NYSE:CBM), worth close to $18.2 million, accounting for 0.1% of its total 13F portfolio. Coming in second is Renaissance Technologies, managed by Jim Simons, which held a $8.6 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Remaining hedge funds that are bullish include Cliff Asness’s AQR Capital Management, Ken Griffin’s Citadel Investment Group and Peter Algert and Kevin Coldiron’s Algert Coldiron Investors.

Seeing as Cambrex Corporation (NYSE:CBM) has witnessed falling interest from the aggregate hedge fund industry, logic holds that there lies a certain “tier” of hedgies who sold off their entire stakes at the end of the first quarter. It’s worth mentioning that Joel Greenblatt’s Gotham Asset Management dumped the biggest investment of the 450+ funds we track, totaling an estimated $1.6 million in stock., and Mike Vranos of Ellington was right behind this move, as the fund dumped about $0.5 million worth. These moves are interesting, as aggregate hedge fund interest fell by 3 funds at the end of the first quarter.

How have insiders been trading Cambrex Corporation (NYSE:CBM)?

Bullish insider trading is at its handiest when the company we’re looking at has seen transactions within the past six months. Over the last 180-day time period, Cambrex Corporation (NYSE:CBM) has experienced zero unique insiders buying, and 7 insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to Cambrex Corporation (NYSE:CBM). These stocks are Dyax Corp. (NASDAQ:DYAX), Osiris Therapeutics, Inc. (NASDAQ:OSIR), Vical Incorporated (NASDAQ:VICL), Obagi Medical Products, Inc. (NASDAQ:OMPI), and AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO). This group of stocks belong to the biotechnology industry and their market caps are closest to CBM’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!